Biogen Inc. (BIIB) Rose To A 2-Week High After FDA Approval

Biogen Inc. (BIIB) announced after the bell Friday that the FDA has approved Spinraza for the treatment of spinal muscular atrophy in pediatric and adult patients.

from RTT - Before the Bell http://ift.tt/2hsE8xh
via IFTTT